The R2GConnect Team has analyzed funding distribution among 684 digital health companies across Europe. The analysis excluded self-funded, bootstrapped companies, companies without external investment and those with over $100 million in funding.
The results reveal:
-
More than half of the total funding was allocated in Top 3 countries: Germany ($1.14B - 22%), the United Kingdom ($1.06B - 21%), and France ($522.6M - 10%).
-
Switzerland and Spain secured almost $800 million, with respective shares of 8% ($400M) and 7% ($382M)
-
Countries including Belgium, Ireland, Sweden, Denmark, Poland, Finland and Netherlands accounted for 3% to 4% of the total funding each, receiving investments between $161M and $229M per country.
-
Hungary, Austria, Norway and Italy captured 1% of the total investment in Europe (from $26M to $60M each)
-
Other countries in Europe with less than 1% individually were not highlighted in the chart including Portugal, Romania, Estonia, Lithuania, Iceland, Slovakia, Russia, Greece, Malta, Ukraine, North Macedonia, Slovenia, Czech Republic, Croatia, Serbia, Latvia and Bulgaria